The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $143.16

Today's change+0.16 +0.11%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $143.16

Today's change+0.16 +0.11%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.

Amgen Inc up (U.S.)$0.16

Amgen Inc closed up Tuesday by (U.S.)$0.16 or 0.11% to (U.S.)$143.16. Over the last five days, shares have lost 4.63% and are down 11.81% for the last year to date. This security has outperformed the S&P 500 by 4.94% during the last year.

Key company metrics

  • Open(U.S.) $141.02
  • Previous close(U.S.) $143.00
  • High(U.S.) $145.63
  • Low(U.S.) $140.82
  • Bid / Ask-- / --
  • YTD % change-11.81%
  • Volume4,211,109
  • Average volume (10-day)4,612,045
  • Average volume (1-month)4,170,965
  • Average volume (3-month)3,860,354
  • 52-week range(U.S.) $130.09 to (U.S.) $181.81
  • Beta0.84
  • Trailing P/E15.79×
  • P/E 1 year forward13.24×
  • Forward PEG1.65×
  • Indicated annual dividend(U.S.) $4.00
  • Dividend yield2.79%
  • Trailing EPS(U.S.) $9.07
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+32.03%

Based on its net profit margin of 32.03%, Amgen Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.02%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue5,5365,7235,3705,033
Total other revenue--------
Total revenue5,5365,7235,3705,033
Gross profit4,4654,6894,2814,000
Total cost of revenue1,0711,0341,0891,033
Total operating expense3,5033,3843,2943,011
Selling / general / administrative1,4161,2441,1601,026
Research & development1,0931,119964894
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--681--
Other operating expenses, total-77-19--58
Operating income2,0332,3392,0762,022
Interest income (expense), net non-operating-284-282-277-252
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9132,1921,9971,876
Income after tax1,8001,8631,6531,623
Income tax, total113329344253
Net income1,8001,8631,6531,623
Total adjustments to net income--------
Net income before extra. items1,8001,8631,6531,623
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,8001,8631,6531,623
Inc. avail. to common incl. extra. items1,8001,8631,6531,623
Diluted net income1,8001,8631,6531,625
Dilution adjustment------2
Diluted weighted average shares761764768770
Diluted EPS excluding extraordinary itemsvalue per share2.372.442.152.11
Dividends per sharevalue per share0.790.790.790.79
Diluted normalized EPSvalue per share2.372.452.242.11